Cannabinoids: Therapeutic Use in Clinical Practice – PMC

1A agonist [] inhibiting the uptake of serotonin, noradrenaline, dopamine, and GABA, which are thought to perhaps facilitate the anxiolytic properties of CBD.nHighlight:CBD is highly lipophilic, has a poor oral bioavailability and accumulates in body fat.nHighlight:metabolized in the liver and the intestine by cytochrome (CYP) P450, CYP2C19, and CYP3A4, and 5′-diphosphoglucuronosyltransferase (UGT) UGT1A7, UGT1A, and UGT2B7 isoforms,n]]>

About Dr. Nathan Goodyear
About Dr. Nathan Goodyear

Dr. Nathan Goodyear, a medical doctor with years of experience in the field of integrative cancer care, has announced the launch of an online training program. This program, available on his new website, will provide individuals with access to video trainings led by Dr. Goodyear himself, covering a range of topics related to integrative cancer care. These trainings will include information on the latest research and techniques in the field, as well as guidance on how to incorporate these approaches into a patient’s overall cancer treatment plan. With this online program, Dr. Goodyear hopes to make his expertise and knowledge more widely accessible, and help more people understand the benefits of integrative cancer care.


Leave a Comment

Your email address will not be published. Required fields are marked *

Skip to content